Agreed dunover, positive pointers except for negligible Evolis sales. We were led to believe almost a decade ago that US sales would reach $100m within 7 years.
Evolis should still be the main brand to promote given its unique hair care features and huge target global market.
Yet the incumbent management continues its flawed obsession on excess M&A. Question why the quest for in house M&A deals now apparently its default stock in trade with beauty products simply camouflage and AN1 as a mere play thing.
Wow, they’ve finally realised the need for a Director of Strategy……part time! The expectation for the grant of 1,000,000 options is a lift in sp to 6 cents.Hopefully that at least arrests the slide in sp having halved and halved again multiple times in recent years.
- Forums
- ASX - By Stock
- Ann: Appendix 4C and Quarterly Activity Report
Agreed dunover, positive pointers except for negligible Evolis...
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable